A phase II study of carboplatin in adenocarcinoma of the oesophagus.
Steel
A
A
East Birmingham Hospital, UK.
Cullen
M H
MH
Robertson
P W
PW
Matthews
H R
HR
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016190:Carboplatin; D004341:Drug Evaluation; D004938:Esophageal Neoplasms / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D010976:Platelet Count
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D016190:Carboplatin